Gland Pharma Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Gland Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2026.

Powered by Capital Market - Live News

The said drug is therapeutically equivalent to the reference listed drug (RLD), Pataday Once Daily Relief, 0.7%, of Alcon Laboratories Inc (Alcon). The said drug indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Gland Pharma is one of the largest and fastest-growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets. It has a wide range of injectables, including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, oncology, and ophthalmic solutions. The company also pioneered Heparin technology in India.

The company?s consolidated net profit increased 12.3% to Rs 183.68 crore on 5.8% rise in net sales to Rs 1486.88 crore in Q2 FY26 over Q2 FY25.

Powered by Capital Market - Live News

Securities in F&O Ban:

Shares of Steel Authority of India(SAIL) and Sammaan Capital are banned from F&O trading on 8 January 2026.

Stocks to Watch:

Gland Pharma has received an approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) filed for Olopatadine Hydrochloride Ophthalmic Solution. The said drug is indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Angel One is scheduled to meet on Thursday, 15 January, 2026 to consider sub-division/split of existing equity shares having face value of Rs 10 each, fully paid up.

Tata Steel?s India crude steel production stood at 6.34 million tons in Q3 FY26, up 12% QoQ and YoY, primarily aided by higher output at Jamshedpur and Kalinganagar facilities.

Meesho?s general manager- business, Megha Agarwal has tendered her resignation with effect from 7 January 2026. Following her exit, Milan Partani, General Manager - User Growth and Content Commerce will now assume the role of General Manager ? Commerce Platform.

Swaraj Engines received a warning letter from BSE and National Stock Exchange of India (NSE) for non-compliance with Regulation 21 (3A) of SEBI Listing Regulations, wherein only one meeting of the Risk Management Committee was held during the financial year 2024-25.

Housing & Urban Development Corporation (HUDCO) has signed a non-binding MoU with the Chhattisgarh government to provide financial assistance of up to Rs 1 lakh crore over five years for housing and infrastructure projects.

Powered by Capital Market - Live News

Net profit of Gland Pharma rose 12.32% to Rs 183.68 crore in the quarter ended September 2025 as against Rs 163.53 crore during the previous quarter ended September 2024. Sales rose 5.77% to Rs 1486.88 crore in the quarter ended September 2025 as against Rs 1405.83 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News